Mansour, Nabeel http://orcid.org/0000-0002-3467-1916
Heinrich, Kathrin
Zhang, Danmei
Winkelmann, Michael
Ingenerf, Maria
Gold, Lukas
Klambauer, Konstantin
Rudelius, Martina
Klauschen, Frederick
von Bergwelt-Baildon, Michael
Ricke, Jens
Heinemann, Volker
Westphalen, C. Benedikt
Kunz, Wolfgang G.
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 1 December 2023
Accepted: 11 May 2024
First Online: 7 June 2024
Change Date: 1 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s40644-024-00724-5
Declarations
:
: All medical records and imaging studies were reviewed with the approval of the LMU Munich Institutional Review Board (LMU Ethics Committee).
: Not applicable.
: WGK: BMS, Boehringer Ingelheim, mintMedical; Need, Inc. CBW reports receipt of a fee for participation in Advisory Board from BMS, Celgene, Rafael, RedHill, Roche, Shire/Baxalta; receipt of a fee as an invited speaker from Amgen, AstraZeneca, Bayer, BMS, Celgene, Chugai, Falk, GSK, Janssen, Merck, MSD, Roche, Servier, Sirtex, Taiho; receipt of a fee for an expert testimony from Janssen; receipt of travel support from Bayer, Celgene, RedHill, Roche, Servier, Taiho; non-financial interest for receipt of research grant both personal and to institution from Roche; non-financial interest for serving as an officer in AIO - Arbeitsgemeinschaft Internistische Onkologie (Germany); non-financial interest for advisory role in EU Commission – DG RTD as a member of the EU Commission Mission Board for Cancer; non-financial interest for serving as an officer in ESMO. KH: Honoraria: Servier, Roche, Taiho, Merck, BMS, streamedup!. Consulting or Advisory role: Servier, MSD (Institutional), Roche (Institutional), Merck, Janssen. Travel support/Expenses: Amgen, Merck, Servier. All other authors have no relevant financial or non-financial interests to disclose.